UNDA 600 (Seroyal USA)
Welcome to the PulseAid listing for the UNDA 600 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Seroyal USA |
NON-PROPRIETARY NAME: | Berberis vulgaris, Rheum, Rhus toxicodendron |
SUBSTANCE NAME: | RHEUM OFFICINALE ROOT; BERBERIS VULGARIS ROOT BARK; TOXICODENDRON PUBESCENS SHOOT |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2017-05-05 |
END MARKETING DATE: | 0000-00-00 |
UNDA 600 HUMAN OTC DRUG Details:
Item Description | UNDA 600 from Seroyal USA |
LABELER NAME: | Seroyal USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6; 6; 6([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL) |
START MARKETING DATE: | 2017-05-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62106-1170_4d505bd6-281a-6c7f-e054-00144ff88e88 |
PRODUCT NDC: | 62106-1170 |
APPLICATION NUMBER: | |
Other RHEUM OFFICINALE ROOT; BERBERIS VULGARIS ROOT BARK; TOXICODENDRON PUBESCENS SHOOT Pharmaceutical Manufacturers / Labelers: